Dr. Andreas Pfaff serves as director, regulatory affairs EU at Symbio, where he leads the European regulatory team and oversees clinical trial submissions and application maintenance across the region. With over 20 years of industry experience, he has developed comprehensive regulatory expertise in both EU and international frameworks, including EU CTR 536/2014, EU Directive 2001/20/EC, ClinO (Switzerland), and UK clinical trial regulations.
He holds a Ph.D. in biology from Johann-Wolfgang-Goethe University in Frankfurt/Main and has been a member of the German Society for Regulatory Affairs (DGRA) since 2017. Prior to joining Symbio, he held various roles at Ist GmbH and Proinnovera, including CRA, lead CRA, project manager, and head of scientific and regulatory affairs.